CIK: 0001602263
Total reported value
$379.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Avexis INC | Stock-Other | 23.71% | — | — | |
| 2 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 18.43% | -3.14% | EXIT | |
| 3 | EWTX | Edgewise Therapeutics, Inc. | Stock-Other | 11.59% | — | — | |
| 4 | ✓ | DBV Technologies | Stock-Other | 8.97% | — | — | |
| 5 | ASND | Ascendis Pharma A/S | Stock-Other | 7.00% | -8.61% | EXIT | |
| 6 | BOLDEUR | Audentes Therapeutics INC | Stock-Other | 3.96% | — | — | |
| 7 | RARXEUR | Ra Pharmaceuticals INC | Stock-Other | 3.95% | -6.10% | EXIT | |
| 8 | CTMX | Cytomx Therapeutics INC | Stock-Other | 3.05% | — | — | |
| 9 | ✓ | Colucid Pharmaceuticals Inc Com | Stock-Other | 2.78% | — | — | |
| 10 | ✓ | Axovant Sciences LTD | Stock-Other | 2.56% | — | — | |
| 11 | HRTX | Heron Therapeutics INC | Stock-Other | 2.55% | — | — | |
| 12 | CHRS | Coherus Oncology INC | Stock-Other | 1.75% | — | — | |
| 13 | STMLEUR | Stemline Therapeutics INC | Stock-Other | 1.62% | — | — | |
| 14 | ✓ | Alcobra Ltd | Stock-Other | 1.55% | — | — | |
| 15 | ✓ | ARCA biopharma Inc | Stock-Other | 1.47% | — | — | |
| 16 | ✓ | Stock-Other | 1.25% | — | — | ||
| 17 | ✓ | Ocera Therapeutics INC | Stock-Other | 1.23% | — | +11.90% | |
| 18 | ✓ | Lipocine INC New | Stock-Other | 0.74% | — | — | |
| 19 | AGLEUSD | Aeglea Biotherapeutics INC | Stock-Other | 0.73% | — | — | |
| 20 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 0.63% | +0.05% | — | |
| 21 | ADVMCHF | Adverum Biotechnologies INC | Stock-Other | 0.39% | +1.16% | NEW | |
| 22 | ✓ | Pronai Therapeutics INC | Stock-Other | 0.09% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BCRX | Biocryst Pharmaceuticals INC | +5.5% | +6.12% | Add |
| 2 | ✓ | Avexis INC | +1.8% | — | Unchanged |
| 3 | EWTX | Edgewise Therapeutics, Inc. | +1.3% | — | Unchanged |
| 4 | BOLDEUR | Audentes Therapeutics INC | +0.2% | — | Unchanged |
| 5 | CHRS | Coherus Oncology INC | 0% | — | Unchanged |
| 6 | ✓ | Pronai Therapeutics INC | 0% | — | Unchanged |
| 7 | ✓ | ARCA biopharma Inc | -0.1% | — | Unchanged |
| 8 | STMLEUR | Stemline Therapeutics INC | -0.1% | — | Unchanged |
| 9 | ADVMCHF | Adverum Biotechnologies INC | -0.2% | — | Unchanged |
| 10 | ✓ | Lipocine INC New | -0.2% | — | Unchanged |
| 11 | ✓ | Ocera Therapeutics INC | -0.2% | +11.90% | Add |
| 12 | ✓ | Colucid Pharmaceuticals Inc Com | -0.3% | — | Unchanged |
| 13 | ✓ | -0.4% | — | Unchanged | |
| 14 | ✓ | Alcobra Ltd | -0.4% | — | Unchanged |
| 15 | AGLEUSD | Aeglea Biotherapeutics INC | -0.4% | — | Unchanged |
| 16 | ASND | Ascendis Pharma A/S | -0.4% | — | Unchanged |
| 17 | ✓ | Axovant Sciences LTD | -0.5% | — | Unchanged |
| 18 | ✓ | DBV Technologies | -1% | — | Unchanged |
| 19 | HRTX | Heron Therapeutics INC | -1% | — | Unchanged |
| 20 | CTMX | Cytomx Therapeutics INC | -1.6% | — | Unchanged |
| 21 | RARXEUR | Ra Pharmaceuticals INC | — | NEW | New buy |
| 22 | RGNX | Regenxbio INC | — | EXIT | Sold out |
| 23 | ONC | Beone Medicines Ltd-adr | — | EXIT | Sold out |
| 24 | ACHNEUR | Achillion Pharmaceuticals | — | EXIT | Sold out |
| 25 | 4XC1 | Kalvista Pharmaceuticals INC | — | NEW | New buy |
| 26 | ZFGNUSD | Zafgen INC | — | EXIT | Sold out |